NYU Langone

 

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist
46:27

NYU Langone

Operationalizing Bladder Cancer Clinic

FEATURING Neal Shore
  • 34 views
  • April 13, 2022
36:43

NYU Langone

Treatment of Locally Advanced Urothelial Cell Carcinoma: Neoadjuvant and Adjuvant Therapy

FEATURING Noah Hahn
  • 435 views
  • April 13, 2022
  • 4
19:07

NYU Langone

NYU Langone Updates on Bladder Preservation for MIBC

FEATURING Victor Adorno Febles
  • 28 views
  • April 13, 2022
  • 1
22:47

NYU Langone

NYU Langone Updates on Upper Tract Urothelial Cancer

FEATURING Anthony Corcoran
  • 72 views
  • April 13, 2022
24:10

NYU Langone

Complications of Radical Cystectomy: Management Strategies

FEATURING Meredith Metcalf
  • 23 views
  • April 13, 2022
17:42

NYU Langone

Radical Cystectomy: Open vs. Robotic Approaches

FEATURING Mohit Gupta
  • 17 views
  • April 13, 2022
  • 1
29:48

NYU Langone

Immune CPI in Combination With Other IO & IO Delivery Systems

FEATURING Gary Steinberg
  • 28 views
  • April 13, 2022
19:34

NYU Langone

Checkpoint Inhibitors in the Treatment of NMIBC

FEATURING Joshua Meeks
  • 35 views
  • April 13, 2022
25:48

NYU Langone

Intravesical BCG: State of the Art 2022

FEATURING Ashish Kamat
  • 49 views
  • April 13, 2022
15:24

NYU Langone

Treatment/Surveillance Algorithms/AUA NMIBC Guidelines

FEATURING LaMont Barlow
  • 64 views
  • April 13, 2022
09:48

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Managing High-Risk NMIBC: Options When BCG Is Not Effective

FEATURING Gary Steinberg
  • 45 views
  • May 23, 2021
08:43

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Novel Therapies for HR-NMIBC: Nadofaragene Firadenovec, CG0070+/-Pembro, EG-70

FEATURING Gary Steinberg
  • 22 views
  • May 23, 2021
08:36

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

High-Risk NMIBC Highlights: Cytokine Therapy, ADCs, Drug Delivery Enhancement

FEATURING Gary Steinberg
  • 36 views
  • May 23, 2021
19:53

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Update on Advanced Urothelial Cancer: Navigating 1L and Beyond Treatment Options

FEATURING Elizabeth R. Plimack
  • 46 views
  • May 21, 2021
18:12

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Expert Q&A Session and Case Discussion for Older Patients With MIBC: Adjuvant PD-1/PD-L1 Therapy for High-Risk Disease, IO vs. Chemo vs. RC

FEATURING Elizabeth R. Plimack, Yair Lotan, Sam Chang, Gary Steinberg, LaMont Barlow, Arjun Balar, Anthony Corcoran, Alexander Sankin
  • 164 views
  • May 5, 2021
15:19

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Strategies for Organ Preservation in UC: Why Remove Every Bad Bladder?

FEATURING Alexander Sankin
  • 215 views
  • May 5, 2021
  • 2
09:28

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Neoadjuvant MIBC: MVAC Followed by RC, Accelerated MVAC, Dose-Dense MVAC + Pegfilgrastim, Checkpoint Inhibition IO

FEATURING Arjun Balar
  • 18 views
  • May 5, 2021
07:43

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Adjuvant MIBC: DFS Data for Atezo vs. Observation, DFS & OS Data for ctDNA+ Patients

FEATURING Arjun Balar
  • 333 views
  • May 5, 2021
  • 2
14:06

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Open vs. Robotic Approaches in Radical Cystectomy: Overview of Oncologic Outcomes

FEATURING Mohit Gupta
  • 11 views
  • May 5, 2021
19:47

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Strategies for Radical Cystectomy Complications: ERAS Guidelines, Prophylactic Antibiotics, Ureteral Strictures Management

FEATURING Anthony Corcoran
  • 14 views
  • May 5, 2021
11:40

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Systemic Therapy for BCG Unresponsive NMIBC: 1L IO in Cis-Ineligible mUC, Pembro for High-Risk Disease; Toxicity Concerns & QoL

FEATURING Arjun Balar
  • 14 views
  • May 5, 2021
15:21

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

BCG Unresponsiveness and Intravesical Therapy in NMIBC: Cost-Effectiveness Analysis of Salvage IT vs. Pembro

FEATURING LaMont Barlow
  • 16 views
  • May 5, 2021
19:06

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

BCG Shortage - Optimal Patient Selection, Alternatives, and “Upfront” RC for High-Risk NMIBC: How Useful Are Intravesical Chemotherapies? How Can We Alter BCG Dosing/Schedule?

FEATURING Richard Matulewicz
  • 13 views
  • May 5, 2021
18:17

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Quality Indicators and Enhanced Imaging in Cystoscopy and TURBT in NMIBC

FEATURING William Huang
  • 24 views
  • May 5, 2021
17:48

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

2021 Updates on Treatment, Surveillance, and Guidelines for NMIBC: How to Perform Quality TURBT? What Options Do We Have When No BCG Is Available? Is Active Surveillance Effective for Low-Risk Patients?

FEATURING Sam Chang
  • 13 views
  • May 5, 2021
05:54

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Update on Upper Tract Urothelial Cell Carcinoma: Distinguishing Features and Diagnosis, Mutational Profiling, Treatment Differences and Problems

FEATURING Yair Lotan
  • 151 views
  • May 5, 2021
10:37

Bladder Cancer Symposium: Update on Medical and Surgical Management for the Urologist

Upper Tract Urothelial Cell Carcinoma Updates: Endocavitary Treatment, Primary Chemoablation, Efficacy Data on Peri-Operative Chemo vs. Surveillance, (Neo)Adjuvant Chemo

FEATURING Yair Lotan
  • 15 views
  • May 5, 2021